Bristol-Myers Squibb Co banner

Bristol-Myers Squibb Co
F:BRM

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
F:BRM
Watchlist
Price: 55.59 EUR 0.25% Market Closed
Market Cap: €112.7B

Wall St Price Targets

BRM Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRM is 59.69 EUR with a low forecast of 34.77 EUR and a high forecast of 72.29 EUR.

Lowest Forecast
Price Target
34.77 EUR
37% Downside
Average Forecast
Price Target
59.69 EUR
7% Upside
Highest Forecast
Price Target
72.29 EUR
30% Upside
Bristol-Myers Squibb Co Competitors:
Price Targets

Revenue
Forecast

8% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.

Gross Profit
Forecast

8% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
8% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is -2%.

Operating Income
Forecast

11% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
11% / Year
Past Growth
-2% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.

Pre-Tax Income
Forecast

11% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-41%
Average Miss
11% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 15%.

Net Income
Forecast

10% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss
10% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BRM's stock price target?
Price Target
59.69 EUR

According to Wall Street analysts, the average 1-year price target for BRM is 59.69 EUR with a low forecast of 34.77 EUR and a high forecast of 72.29 EUR.

What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.

What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is -2%.

What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.

What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.

Back to Top